100% bioavailability: IV delivery achieves full absorption vs 10-30% for oral supplements (NIH data) Rapid onset: Effects felt within minutes for hydration, within hours for energy and immunity Higher concentrations: IV allows blood levels of vitamin C (for example) 50-70x higher than oral maximum Bypasses GI issues: Effective even for patients with malabsorption, IBS, or gastritis Customisable: Formulas tailored to individual deficiencies identified through blood work A 2022 systematic review in Nutrients journal confirmed that IV vitamin C at high doses achieves plasma concentrations sufficient for antioxidant and immune-modulating effects that are pharmacologically impossible through oral intake
It supports detox, brightens skin, protects cells, and reduces stress inside the body
It also has a distinctive regulatory position: it was previously an FDA-approved product (marketed as Geref, a diagnostic agent) before being voluntarily withdrawn from the market, and that prior-approval history has given it a more stable standing for compounding than most other peptides
Over-the-Counter Medications in Pregnancy
Key timing considerations: Side effect profile tends to be somewhat milder than semaglutide, which may reduce the importance of sleep-through timing Same 48-hour minimum spacing rule applies if changing injection days Pre-filled pen format means no reconstitution time, making spontaneous timing adjustments easier Many dulaglutide users report minimal side effects after the first month, at which point timing becomes purely a convenience decision Retatrutide (weekly injectable, investigational) Dosing frequency: Once weekly Half-life: Data from Phase 2 trials suggest approximately 6 days Peak concentration: Approximately 24 to 72 hours after injection Recommended timing approach: As a triple agonist (GLP-1/GIP/glucagon), retatrutide may produce a different side effect profile than pure GLP-1 or dual GLP-1/GIP agonists